180 related articles for article (PubMed ID: 27405768)
1. New biomarkers and therapeutics can be discovered during COPD-lung cancer transition.
Wang X
Cell Biol Toxicol; 2016 Oct; 32(5):359-61. PubMed ID: 27405768
[No Abstract] [Full Text] [Related]
2. Genomic mechanisms of transformation from chronic obstructive pulmonary disease to lung cancer.
Wang DC; Shi L; Zhu Z; Gao D; Zhang Y
Semin Cancer Biol; 2017 Feb; 42():52-59. PubMed ID: 27840275
[TBL] [Abstract][Full Text] [Related]
3. Aberrant epigenetic regulation: a central contributor to lung carcinogenesis and a new therapeutic target.
Juergens RA; Rudin CM
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714528
[TBL] [Abstract][Full Text] [Related]
4. Cancer biology and Mr. Darwin.
Gatenby R
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):67-68. PubMed ID: 28412279
[No Abstract] [Full Text] [Related]
5. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
Mittal V
Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
[TBL] [Abstract][Full Text] [Related]
6. Genomic complexity: a call to action.
Hait WN; Levine AJ
Sci Transl Med; 2014 Sep; 6(255):255cm10. PubMed ID: 25253671
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research.
Punturieri A; Szabo E; Croxton TL; Shapiro SD; Dubinett SM
J Natl Cancer Inst; 2009 Apr; 101(8):554-9. PubMed ID: 19351920
[TBL] [Abstract][Full Text] [Related]
8. Targeting dynamics of subclones of GI, liver and pancreatic cancers.
Ziogas DE; Glantzounis G; Liakakos T; Roukos DH
Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):773-6. PubMed ID: 27143511
[No Abstract] [Full Text] [Related]
9. Innovative Clinical Trials: The LUNG-MAP Study.
Steuer CE; Papadimitrakopoulou V; Herbst RS; Redman MW; Hirsch FR; Mack PC; Ramalingam SS; Gandara DR
Clin Pharmacol Ther; 2015 May; 97(5):488-91. PubMed ID: 25676724
[TBL] [Abstract][Full Text] [Related]
10. Lung Cancer Genomics in the Era of Accelerated Targeted Drug Development.
Wijesinghe P; Bollig-Fischer A
Adv Exp Med Biol; 2016; 890():1-23. PubMed ID: 26703796
[TBL] [Abstract][Full Text] [Related]
11. Personalised medicine for nonsmall cell lung cancer.
Mascaux C; Tomasini P; Greillier L; Barlesi F
Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29141962
[TBL] [Abstract][Full Text] [Related]
12. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
13. New developments on targeted cancer therapy: Multi-faceted issues in targeted cancer therapy.
Bao J; Qiao L
Cancer Lett; 2017 Feb; 387():1-2. PubMed ID: 28038727
[No Abstract] [Full Text] [Related]
14. The HLJ1-targeting drug screening identified Chinese herb andrographolide that can suppress tumour growth and invasion in non-small-cell lung cancer.
Lai YH; Yu SL; Chen HY; Wang CC; Chen HW; Chen JJ
Carcinogenesis; 2013 May; 34(5):1069-80. PubMed ID: 23306212
[TBL] [Abstract][Full Text] [Related]
15. Evolutionary scalpels for dissecting tumor ecosystems.
Rosenbloom DIS; Camara PG; Chu T; Rabadan R
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):69-83. PubMed ID: 27923679
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer stem cells: The root of resistance.
MacDonagh L; Gray SG; Breen E; Cuffe S; Finn SP; O'Byrne KJ; Barr MP
Cancer Lett; 2016 Mar; 372(2):147-56. PubMed ID: 26797015
[TBL] [Abstract][Full Text] [Related]
17. A variant in 3'-untranslated region of KRAS compromises its interaction with hsa-let-7g and contributes to the development of lung cancer in patients with COPD.
Hu H; Zhang L; Teng G; Wu Y; Chen Y
Int J Chron Obstruct Pulmon Dis; 2015; 10():1641-9. PubMed ID: 26316738
[TBL] [Abstract][Full Text] [Related]
18. Changing mutational and adaptive landscapes and the genesis of cancer.
Liggett LA; DeGregori J
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):84-94. PubMed ID: 28167050
[TBL] [Abstract][Full Text] [Related]
19. Mathematical models of cell phenotype regulation and reprogramming: Make cancer cells sensitive again!
Wooten DJ; Quaranta V
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):167-175. PubMed ID: 28396217
[TBL] [Abstract][Full Text] [Related]
20. Biomarker strategy in lung cancer.
Esencay M; Watson A; Mukherjee K; Hanicq D; Gubernick SI
Nat Rev Drug Discov; 2018 Jan; 17(1):13-14. PubMed ID: 28959953
[No Abstract] [Full Text] [Related]
[Next] [New Search]
